Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2011-06-23 PAPPAJOHN JOHN Director Grant or award · Stock option (right to buy) +20,000 20,000
2011-05-25 PAPPAJOHN JOHN Director Sale −50,000 $3.68 $184K 394,044
2010-11-22 PAPPAJOHN JOHN Director Conversion +444,044 $2.54 $1.1M 444,044
2010-11-22 PAPPAJOHN JOHN Director Conversion · 10% Convertible Note −0 0
2010-06-23 PAPPAJOHN JOHN Director Grant or award · Stock option (right to buy) +20,000 20,000
2010-05-27 PAPPAJOHN JOHN Director Purchase +45,656 $1.51 $69K 911,164
2010-05-27 PAPPAJOHN JOHN Director Purchase +45,656 $1.51 $69K 911,164
2010-05-26 PAPPAJOHN JOHN Director Purchase +54,344 $1.49 $81K 865,508
2010-05-26 PAPPAJOHN JOHN Director Purchase +54,344 $1.49 $81K 865,508
2009-12-11 PAPPAJOHN JOHN Director Purchase +100,000 $1.19 $119K 811,164
2009-08-05 PAPPAJOHN JOHN Director Grant or award · Stock Option (right to buy) +20,000 20,000
2009-07-28 PAPPAJOHN JOHN Director Grant or award · 10% Unsecured Convertible Note +0
2009-07-28 PAPPAJOHN JOHN Director Grant or award · Common Stock Warrant +133,333 133,333
2009-03-26 PAPPAJOHN JOHN Director Sale −17,735 $0.00 $2 711,164

Page 1 of 1 · 14 trades